Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo-Reference-Cited by-同舟云学术

Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo

Published:2021-12-01 Issue:6 Volume:321 Page:F785-F798
ISSN:1931-857X
Container-title:American Journal of Physiology-Renal Physiology
language:en
Short-container-title:American Journal of Physiology-Renal Physiology

Author:

Küng Catharina J.¹,Haykir Betül¹,Schnitzbauer Udo¹,Egli-Spichtig Daniela¹,Hernando Nati¹,Wagner Carsten A.¹^ORCID

Affiliation:

1. Institute of Physiology, University of Zurich and National Center of Competence in Research Kidney.CH, Zurich, Switzerland

Abstract

The hormone fibroblast growth factor 23 (FGF23) controls phosphate homeostasis by regulating renal phosphate excretion. FGF23 acts on several phosphate transporters in the kidney. Here, we define the time course of this action and demonstrate how phosphate transporters NaPi-IIa and NaPi-IIc are degraded.

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

American Physiological Society

Subject

Physiology

Link

https://journals.physiology.org/doi/pdf/10.1152/ajprenal.00250.2021

Reference57 articles.

1. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

2. Renal phosphate wasting disorders: clinical features and pathogenesis

3. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia

4. 1α,25-Dihydroxyvitamin D3upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience;Journal of Nephrology;2024-02-03

2. Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI;Journal of the American Society of Nephrology;2024-01-04

3. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria;Clinical Kidney Journal;2023-11-01

4. Tumor-induced osteomalacia: An overview;Best Practice & Research Clinical Endocrinology & Metabolism;2023-10

5. The basics of phosphate metabolism;Nephrology Dialysis Transplantation;2023-09-02